Stocktoria
Arcadia Biosciences, Inc. RKDA
Nasdaq · XNAS · stock · Crude Petroleum & Natural Gas · website · IPO 2015-05-15
Arcadia Biosciences, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $4.9M | $5.0M | $4.5M | $7.4M | $6.8M |
| R&D expense | $9,000 | $53,000 | $64,000 | $1.5M | $3.9M |
| SG&A expense | $7.0M | $9.6M | $8.2M | $15.0M | $22.9M |
| Operating income | -$2.5M | -$3.6M | -$6.1M | -$14.0M | -$35.5M |
| Interest expense | — | — | — | — | $20,000 |
| Income tax | $8,000 | $8,000 | $8,000 | $14,000 | $2,000 |
| Net income | -$2.3M | -$7.0M | -$14.0M | -$15.4M | -$14.7M |
| EPS (diluted) | $-1.71 | $-5.17 | $-11.29 | $-25.65 | $-27.56 |
| Operating cash flow | -$4.7M | -$9.6M | -$15.3M | -$14.0M | -$25.9M |
| Free cash flow | -$4.7M | -$9.6M | -$15.3M | -$14.0M | -$26.9M |
| Cash & equivalents | $259,000 | $4.2M | $6.5M | $20.6M | $28.7M |
| Inventory | $1.2M | $904,000 | $837,000 | $2.3M | $4.4M |
| Total assets | $6.5M | $13.5M | $19.7M | $28.9M | $43.9M |
| Total liabilities | $2.4M | $7.3M | $7.0M | $8.0M | $12.7M |
| Shareholders' equity | $4.1M | $6.2M | $12.8M | $21.0M | $31.2M |
Source: SEC EDGAR filings · CIK 0001469443 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.